JPRN-UMIN000012420已完成1 期
Randomized, double-blind, placebo-controlled, clinical trial with OSD-001 for skin lesions due to tuberous sclerosis complex. - Clinical trial for development of OSD-001 for skin lesions due to tuberous sclerosis complex.
Department of Dermatology Graduate School of Medicine, Osaka University0 个研究点目标入组 36 人开始时间: 2013年11月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who cannot carry out this treatment plan or follow-up assessment. 2)Patients who have serious skin lesions such as erosions or ulcers. 3)Patients who have allergy to macrolide antibiotics. 4)Patients who received sirolimus, everolimus or temsirolimus administration within twelve months prior to the study entry. 5)Patients who received topical treatment of tacrolimus, vitamin D or steroid within three months prior to the study entry. 6)Patients who received laser therapy or surgical therapy within six months prior to the study entry. 7)Patients during pregnancy or lactation. 8)Patients who were judged unsuitable for this clinical trial by the investigator.
研究者
相似试验
进行中（未招募）
1 期
Clinical study to investigate if Opicapone 50mg can reduce pain associated to Parkinson's diseaseParkinson's disease patients with wearing-off motor fluctuations and associated pain.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2020-001175-32-ITBIAL-Portela & Ca, S.A.176
进行中（未招募）
1 期
Clinical study to evaluate the effect of opicapone 50 mg in the pain associated to Parkinson’s disease.Parkinson's disease patients with wearing-off motor fluctuations andassociated pain.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2020-001175-32-GBBial - Portela & Ca, S.A.176
进行中（未招募）
1 期
Clinical study to investigate if Opicapone 50mg can reduce pain associated to Parkinson’s diseaseEUCTR2020-001175-32-PTBial - Portela & Ca, S.A.176
进行中（未招募）
1 期
Clinical study to investigate if Opicapone 50mg can reduce pain associated to Parkinson’s diseaseParkinson's disease patients with wearing-off motor fluctuations and associated pain.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2020-001175-32-CZBial - Portela & Ca, S.A.176
进行中（未招募）
1 期
Clinical study to investigate if Opicapone 50mg can reduce pain associated to Parkinson’s diseaseParkinson's disease patients with wearing-off motor fluctuations and associated pain.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2020-001175-32-PLBial - Portela & Ca, S.A.176